Jonathan Maher
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 8
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 22
- Molecular Biology top 5%
- Genomics, phytochemicals, and oxidative stress 19
- Glutathione Transferases and Polymorphisms 8
- Hepatology top 5%
- Biochemistry top 2%
-
- Pharmacological Effects and Toxicity Studies 7
-
- Liver Disease Diagnosis and Treatment 6
-
- MicroRNA in disease regulation 4
- Co-authors
- Curtis D. KlaassenMasayuki YamamotoAngela L. SlittXingguo ChengTakafumi SuzukiMatthew Z. DieterNathan J. CherringtonHozumi Motohashi
- Journals
- Drug Metabolism and Disposition (9 papers)Toxicology and Applied Pharmacology (6 papers)Toxicological Sciences (3 papers)
- Partner nations
- United StatesJapanCzechia
In The Last Decade
Jonathan Maher
53 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 116
- Pharmacology 711
- Oncology 1.3k
- Molecular Biology 2.3k
- Hepatology 213
- Biochemistry 187
Countries citing papers authored by Jonathan Maher
This map shows the geographic impact of Jonathan Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Maher more than expected).
Fields of papers citing papers by Jonathan Maher
This network shows the impact of papers produced by Jonathan Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Maher. The network helps show where Jonathan Maher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2020 | 6 | |
| 3 | 2017 | 20 | |
| 4 | 2012 | 62 | |
| 5 | 2010 | 196 | |
| 6 | 2010 | 47 | |
| 7 | 2010 | 165 | |
| 8 | 2009 | 73 | |
| 9 | 2008 | 93 | |
| 10 | 2008 | 123 | |
| 11 | 2007 | 263 | |
| 12 | 2007 | 30 | |
| 13 | 2007 | 124 | |
| 14 | 2006 | 38 | |
| 15 | 2006 | 81 | |
| 16 | 2006 | 50 | |
| 17 | 2005 | 137 | |
| 18 | 2005 | 203 | |
| 19 | 2004 | 28 | |
| 20 | 2003 | 67 |
About Jonathan Maher
Jonathan Maher is a scholar working on Pharmacology, Oncology and Molecular Biology, having authored 53 papers that have together received 4.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Genomics, phytochemicals, and oxidative stress (19 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Glutathione Transferases and Polymorphisms (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Pharmacology (711 citations), Oncology (1.3k citations) and Molecular Biology (2.3k citations). Jonathan Maher has collaborated with scholars based in United States, Japan and Czechia. Frequent co-authors include Curtis D. Klaassen, Masayuki Yamamoto, Angela L. Slitt, Xingguo Cheng, Takafumi Suzuki, Matthew Z. Dieter, Nathan J. Cherrington, Hozumi Motohashi, Yuji Tanaka and José E. Manautou. Their work appears in journals such as Drug Metabolism and Disposition, Toxicology and Applied Pharmacology, Toxicological Sciences, Molecular and Cellular Biology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.